Perrigo Sets Strategy For Global Infant Formula Growth
This article was originally published in The Tan Sheet
Executive Summary
The private labeler’s more than 60 planned product launches include Codex-compliant infant formulas. The firm also sees marketing formula in plastic containers as a U.S. sales driver.
You may also be interested in...
Bloom & Blossom Sprouts Perrigo Into Branded Formula Space
The firm launches Bloom & Blossom Ultra Gentle Formula soon after beginning to report international sales growth driven by branded OTC drugs and nutritional supplements. The latest brand move comes less than a week before Mylan tenders its hostile takeover offer to Perrigo shareholders.
Bloom & Blossom Sprouts Perrigo Into Branded Formula Space
The firm launches Bloom & Blossom Ultra Gentle Formula soon after beginning to report international sales growth driven by branded OTC drugs and nutritional supplements. The latest brand move comes less than a week before Mylan tenders its hostile takeover offer to Perrigo shareholders.
Perrigo’s Irish Move Sets Stage For International Boost, Net Revenue Gain
OTC private label leader Perrigo acquires Irish firm Elan for $8.6 billion in a deal that will bring tax savings from being incorporated in Ireland, provide a stage for European expansion and tap into Elan’s royalty rights. “Simply stated, we're going to be able to further our international platform,” CEO Joseph Papa says.